Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Apar Kishor Ganti

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Cancer Investigation|January 16, 2010
Epidermal growth factor receptor signaling in nonsmall cell lung cancerApar Kishor Ganti
Oncology (Williston Park, N.Y.)|June 26, 2018
Newly Diagnosed Lung Cancer: Which Molecular Tests Are Needed for Optimal Treatment Decision Making?Apar Kishor Ganti
Expert Opinion on Biological Therapy|June 30, 2006
Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the futureAnil Potti, Apar Kishor Ganti
Critical Reviews in Oncology/Hematology|July 6, 2010
Targeted anti-cancer therapy in the elderlyWilson Gonsalves, Apar Kishor Ganti
Cancer Treatment Reviews|January 11, 2011
Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancerApar Kishor Ganti, Anne Kessinger
Expert Review of Anticancer Therapy|December 1, 2015
Emerging targeted therapies in non-small cell lung cancerNabin Khanal, Apar Kishor Ganti
Journal of Surgical Oncology|April 19, 2017
Lung cancer-A global perspectiveAmanda McIntyre, Apar Kishor Ganti
Oncotargets and Therapy|July 17, 2023
Clinical Utility of Mobocertinib in the Treatment of NSCLC - Patient Selection and Reported OutcomesAbram Arnold, Apar Kishor Ganti
Journal of Thoracic Disease|March 30, 2018
Immunotherapy in treatment naïve advanced non-small cell lung cancerVinicius Ernani, Apar Kishor Ganti
Journal of Geriatric Oncology|March 1, 2016
Concurrent chemoradiotherapy in older adults with squamous cell head & neck cancer: Evidence and managementVivek Verma, Apar Kishor Ganti
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Cancer Investigation|January 16, 2010
Epidermal growth factor receptor signaling in nonsmall cell lung cancerApar Kishor Ganti
Oncology (Williston Park, N.Y.)|June 26, 2018
Newly Diagnosed Lung Cancer: Which Molecular Tests Are Needed for Optimal Treatment Decision Making?Apar Kishor Ganti
Expert Opinion on Biological Therapy|June 30, 2006
Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the futureAnil Potti, Apar Kishor Ganti
Critical Reviews in Oncology/Hematology|July 6, 2010
Targeted anti-cancer therapy in the elderlyWilson Gonsalves, Apar Kishor Ganti
Cancer Treatment Reviews|January 11, 2011
Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancerApar Kishor Ganti, Anne Kessinger
Expert Review of Anticancer Therapy|December 1, 2015
Emerging targeted therapies in non-small cell lung cancerNabin Khanal, Apar Kishor Ganti
Journal of Surgical Oncology|April 19, 2017
Lung cancer-A global perspectiveAmanda McIntyre, Apar Kishor Ganti
Oncotargets and Therapy|July 17, 2023
Clinical Utility of Mobocertinib in the Treatment of NSCLC - Patient Selection and Reported OutcomesAbram Arnold, Apar Kishor Ganti
Journal of Thoracic Disease|March 30, 2018
Immunotherapy in treatment naïve advanced non-small cell lung cancerVinicius Ernani, Apar Kishor Ganti
Journal of Geriatric Oncology|March 1, 2016
Concurrent chemoradiotherapy in older adults with squamous cell head & neck cancer: Evidence and managementVivek Verma, Apar Kishor Ganti
Pageof 17